Mohsen Farrokhpour
- Co-authors
- Najmeh MoradiMahdi YadollahzadehMitra RanjbarShahrokh IzadiFarhad ZamaniHadith RastadEsmaeil MortazSanjoy Ghosh
- Topics
- COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 and COVID-19 Research (2 papers)Pancreatitis Pathology and Treatment (2 papers)
- Cited by
- Infectious DiseasesNeurologyEquine
- Journals
- Food Science & NutritionHepatitis MonthlyOpen Access Macedonian Journal of Medical Sciences
- Partner nations
- IranCanadaUnited Kingdom
In The Last Decade
Mohsen Farrokhpour
9 papers receiving 52 citations
Peers
Comparison fields: 5 of 40
- Infectious Diseases 35
- Neurology 11
- Pulmonary and Respiratory Medicine 9
- Surgery 6
- Oncology 6
Countries citing papers authored by Mohsen Farrokhpour
This map shows the geographic impact of Mohsen Farrokhpour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Farrokhpour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Farrokhpour more than expected).
Fields of papers citing papers by Mohsen Farrokhpour
This network shows the impact of papers produced by Mohsen Farrokhpour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Farrokhpour. The network helps show where Mohsen Farrokhpour may publish in the future.
Co-authorship network of co-authors of Mohsen Farrokhpour
This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Farrokhpour. A scholar is included among the top collaborators of Mohsen Farrokhpour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Farrokhpour. Mohsen Farrokhpour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 22 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | Endogenous lipoid pneumonia associated with rheumatoid arthritis, Tuberculosis and cytomegalovirus infection | 1 |
| 10 | Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation. | 3 |
About Mohsen Farrokhpour
Mohsen Farrokhpour is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine and Neurology, having authored 10 papers that have together received 53 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (35 citations), Neurology (11 citations) and Equine (1 citation). Mohsen Farrokhpour has collaborated with scholars based in Iran, Canada and United Kingdom. Frequent co-authors include Najmeh Moradi, Mahdi Yadollahzadeh, Mitra Ranjbar, Shahrokh Izadi, Farhad Zamani, Hadith Rastad, Esmaeil Mortaz, Sanjoy Ghosh, Khadijeh Makhdoomi and Fahimeh Safarnezhad Tameshkel. Their work appears in journals such as Food Science & Nutrition, Hepatitis Monthly and Open Access Macedonian Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.